Duncan C Miller
6PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 01, 2023
Modulation of ERK5 Activity as a Therapeutic Anti-Cancer Strategy.Duncan C Miller, Suzannah J Harnor, Mathew P Martin
|Nov 11, 2022
Mapping Ligand Interactions of Bromodomains BRD4 and ATAD2 with FragLites and PepLites─Halogenated Probes of Druglike and Peptide-like Molecular Interactions.Gemma Davison, Mathew P Martin, Shannon Turberville
|Apr 25, 2022
Parallel Optimization of Potency and Pharmacokinetics Leading to the Discovery of a Pyrrole Carboxamide ERK5 Kinase Domain Inhibitor.Duncan C Miller, Tristan Reuillon, Lauren Molyneux
|Jul 02, 2021
An Alkynylpyrimidine-Based Covalent Inhibitor That Targets a Unique Cysteine in NF-κB-Inducing Kinase.Islam Al-Khawaldeh, Mohammed J Al Yasiri, Gregory G Aldred
|Mar 24, 2021
Structure-Based Design of Potent and Orally Active Isoindolinone Inhibitors of MDM2-p53 Protein-Protein Interaction.Gianni Chessari, Ian R Hardcastle, Jong Sook Ahn
|Feb 23, 2018
Identification of a novel ligand for the ATAD2 bromodomain with selectivity over BRD4 through a fragment growing approach.Duncan C Miller, Mathew P Martin, Santosh Adhikari
Pageof 1
Frequent Collaborators
5 joint publications
Celine Cano
4 joint publications
Suzannah J Harnor
3 joint publications
Ian R Hardcastle
3 joint publications
Michael J Waring
2 joint publications
Bernard T Golding
1 joint publications
Alfie Brennan
1 joint publications
Gianni Chessari
1 joint publications
Christopher N Johnson
1 joint publications
Emiliano Tamanini
1 joint publications
Gemma Davison
